DS3201
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for DS3201, covering 2026-04-24 to 2026-04-24. Get the full timeline:
Most recent: Clinical Trial Update: DS3201 and Ipilimumab for the Treatment of Metastatic Prostate, Urothelial and Renal Cell Cancers [Phase 1]